Effect of Metformin Gel on Guided Bone Regeneration Around Immediate Dental Implant at Posterior Maxillary Region
MET-GBR
Evaluation of the Efficacy of Metformin Topical Application on Bone Healing Around Immediate Dental Implants
1 other identifier
interventional
12
1 country
2
Brief Summary
To evaluate, by standardized radiographic follow-up, whether locally delivered 1% metformin gel improves bone healing around immediately placed dental implants augmented with GBR.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedFirst Submitted
Initial submission to the registry
August 12, 2026
CompletedFirst Posted
Study publicly available on registry
August 18, 2026
CompletedAugust 18, 2026
August 1, 2026
3 years
August 12, 2026
August 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Peri-implant Bone Density
Peri-implant bone density was assessed using cone-beam computed tomography (CBCT). Bone density was measured as the mean gray-scale value within a standardized region of interest adjacent to the dental implant. Changes in peri-implant bone density were compared between the metformin and control groups.
Baseline (immediately after implant placement) , 6 months, and 12 months.
Secondary Outcomes (1)
Change in Crestal Bone Level
Baseline (immediately after implant placement) and 6, 12 months.
Study Arms (2)
study group
EXPERIMENTALParticipants received immediate dental implant placement with guided bone regeneration using an alloplastic bone graft and collagen membrane, with topical application of 1% metformin gel around the implant.
control group
EXPERIMENTALParticipants received immediate dental implant placement with guided bone regeneration using the same alloplastic bone graft and collagen membrane protocol, without topical metformin gel.
Interventions
A 1% metformin gel was topically applied around the dental implant at the time of immediate implant placement. The intervention was used in conjunction with guided bone regeneration using an alloplastic bone graft and collagen membrane in the posterior maxillary region.
Immediate dental implant placement was performed following atraumatic extraction in the posterior maxillary region. Guided bone regeneration was performed using an alloplastic bone graft and collagen membrane around the implant. This procedure was performed in both study groups; participants in the control group received this protocol without topical metformin gel.
Eligibility Criteria
You may qualify if:
- \. All patients were free from any systemic diseases according to criteria of Cornell Medical Index and its modification(184).
- \. Patent's age at least 18 years old. 3. Patients had remaining roots or badly decayed hopeless teeth indicated for extraction for immediate implant placement in the posterior maxilla region.
- \. Extraction socket has sufficient bone quality and quantity amenable for implant length that is not less than 10 mm and of suitable diameter.
- \. The implant recipient site should be free from any pathological conditions. 6. Patients with Good Oral Hygiene, and instructed for oral hygiene measures
You may not qualify if:
- Patients with bad oral hygiene. 2. Uncontrolled systemic diseases that complicate bone healing. 3. Presence of any pathology in the implant site. 4. Heavy smokers, alcohol or drug abuse patients. 5. Patients with para functional habits such as bruxism and clenching. 6. Conditions that might lead to alteration of bone region as osteoporosis or Paget's disease.
- \. Any medicines such as bisphosphonates or steroids that affect bone turn over.
- \. History of chemotherapy or radiotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Faculty of Dental Medicine, Al-Azhar University, Assiut Branch
Asyut, Assiut Governorate, 71511, Egypt
Department of Oral and Maxillofacial Surgery, Faculty of Dental Medicine, Al-Azhar University, Assiut Branch
Asyut, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Postgraduate Researcher, Department of Oral and Maxillofacial Surgery
Study Record Dates
First Submitted
August 12, 2026
First Posted
August 18, 2026
Study Start
November 1, 2022
Primary Completion
November 15, 2025
Study Completion
December 15, 2025
Last Updated
August 18, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because no data-sharing plan was included in the original study protocol or ethics approval, and participant confidentiality must be maintained.